Vantive to Sell Most of Its Hemodialysis Business to Rockwell Medical
Vantive agreed to sell the bulk of its hemodialysis assets to Rockwell Medical, with closing targeted for mid-2027, TradingView reported on November 3, 2026.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Vantive, a vital organ therapy company, has signed a definitive agreement to sell most of its hemodialysis business and related operations to Rockwell Medical (RMTI), according to TradingView. The package covers dialysis concentrates, HD monitors, water treatment equipment, consumables and technical services. Vantive's manufacturing plant in Medolla, Italy will also move to Rockwell. The dialyzer line, including the Theranova device used for HDx therapy, stays with Vantive. Closing is expected in mid-2027, pending regulatory clearances and other standard conditions.
why it matters
For markets, the deal narrows Vantive toward home dialysis and critical care, while Rockwell Medical becomes a company focused solely on hemodialysis. The financial terms were not disclosed in the report, so the effect on either company's earnings is hard to gauge at this stage.
market impact
RMTI: the Vantive asset purchase expands its hemodialysis business, with closing planned for mid-2027
tags
instruments
sources
- Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical — TradingView, 3 November 2026 at 11:01 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗